Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FY23L
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,670
Award facts
- Contract value 100% obligated
- $29,669.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $29,669.58 by the Defense Logistics Agency on September 17, 2025, for the supply of Entyvio 300 mg vials. The contract carries an ultimate completion date of October 8, 2025, and utilizes no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for military healthcare facilities worldwide.
Entyvio is a specialty biologic medication used in the treatment of inflammatory bowel diseases, and this delivery order represents part of the company's established role as a critical supplier within the federal pharmaceutical supply chain. The Defense Logistics Agency leverages its IDC with DMS Pharmaceutical Group to efficiently source branded and generic prescription drugs, biologics, and medical consumables across multiple product categories to support Department of Defense healthcare operations globally. The company's consistent success in securing federal pharmaceutical contracts demonstrates its operational capability and reliability in meeting the stringent requirements of military medical supply chains.
Quick answers
Who was awarded contract SPE2DB25FY23L?
SPE2DB25FY23L was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FY23L worth?
The government has obligated $29,670 on SPE2DB25FY23L.
Is contract SPE2DB25FY23L an order under another contract?
Yes. SPE2DB25FY23L is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB25FY23L competed?
The extent of competition for SPE2DB25FY23L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award